It is interesting that in our discovery cohort, patients with pulmonary fibrosis are not only the ones with higher anti-CXCL4 antibody reactivity, but also those with a higher IFN-I signature in the blood. This evidence concerns the gene PF4 and pulmonary fibrosis.